TR201720845A1 - Oral farmasöti̇k terki̇pler - Google Patents
Oral farmasöti̇k terki̇pler Download PDFInfo
- Publication number
- TR201720845A1 TR201720845A1 TR2017/20845A TR201720845A TR201720845A1 TR 201720845 A1 TR201720845 A1 TR 201720845A1 TR 2017/20845 A TR2017/20845 A TR 2017/20845A TR 201720845 A TR201720845 A TR 201720845A TR 201720845 A1 TR201720845 A1 TR 201720845A1
- Authority
- TR
- Turkey
- Prior art keywords
- lung diseases
- oral pharmaceutical
- pharmaceutical components
- asthma
- agent
- Prior art date
Links
- 239000005426 pharmaceutical component Substances 0.000 title 1
- 208000019693 Lung disease Diseases 0.000 abstract 2
- 208000006673 asthma Diseases 0.000 abstract 2
- 208000009079 Bronchial Spasm Diseases 0.000 abstract 1
- 208000014181 Bronchial disease Diseases 0.000 abstract 1
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- 206010006482 Bronchospasm Diseases 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010014561 Emphysema Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000048 adrenergic agonist Substances 0.000 abstract 1
- 229940126157 adrenergic receptor agonist Drugs 0.000 abstract 1
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 abstract 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 238000009097 single-agent therapy Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Mevcut buluş; astım, bronşiyal astım, kronik bronşit, kronik obstruktif akciğer hastalığı (KOAH), amfizem ve bronkospazm gibi akciğer hastalıklarının ve sekresyonun bulunduğu diğer akciğer hastalıklarının profilaktik ve/veya semptomatik ve/veya terapötik tedavisinde kullanılmak üzere beta-2-adrenerjik reseptör agonisti olan uygun etken madde ve/veya farmasötik olarak kabul edilebilir türevlerinin monoterapi olarak tek başına kullanıldığı veya bu etken maddenin diğer uygun aktif ajan/lar ile kombine tedavi olarak kullanıldığı farmasötik bileşim/ler ile ilgilidir.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/20845A TR201720845A1 (tr) | 2017-12-19 | 2017-12-19 | Oral farmasöti̇k terki̇pler |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2017/20845A TR201720845A1 (tr) | 2017-12-19 | 2017-12-19 | Oral farmasöti̇k terki̇pler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201720845A1 true TR201720845A1 (tr) | 2019-07-22 |
Family
ID=67900415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2017/20845A TR201720845A1 (tr) | 2017-12-19 | 2017-12-19 | Oral farmasöti̇k terki̇pler |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201720845A1 (tr) |
-
2017
- 2017-12-19 TR TR2017/20845A patent/TR201720845A1/tr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA519402319B1 (ar) | Rho- مشتقات أميد التيروسين كمثبطات لإنزيم الكيناز | |
| MX2019005526A (es) | Derivados biciclicos de dihidropirimidina-carboxamida como inhibidores de rho-cinasa. | |
| PH12020551425A1 (en) | Rimegepant for cgrp related disorders | |
| BR112015006571A2 (pt) | composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica, e, método para a profilaxia ou tratamento de asma, doença pulmonar obstrutiva crônica e distúrbios respiratórios relacionados | |
| MX2021014113A (es) | Derivados de aminoquinazolina como inhibidores del purinoreceptor 3 de p2x (p2x3). | |
| EA201270561A1 (ru) | Антагонисты рецептора cgrp | |
| PH12017502087A1 (en) | Tiotropium inhalation solution for nebulization | |
| MX2019006938A (es) | Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon. | |
| EA202092976A1 (ru) | Устойчивые фармацевтические композиции для дозированных ингаляторов под давлением | |
| MX2016014756A (es) | Nuevo tratamiento. | |
| AR073528A1 (es) | Particulas inhalables que comprenden tiotropio | |
| EP2682097A3 (en) | Dry Powder Inhalers Comprising A Carrier Other Than Lactose | |
| MX2021000270A (es) | Derivados de la tirosina amida como inhibidores de la rho- cinasa. | |
| WO2011093820A3 (en) | A pharmaceutical combination comprising tiotropium | |
| MX2018014752A (es) | Beta-horquilla peptidomimetica con actividad inhibidora de elastasa y formas de dosificacion en aerosol de la misma. | |
| CL2023002871A1 (es) | Composiciones nasales que comprenden alcaftadina | |
| CL2008000973A1 (es) | Compuestos derivados de 1-oxo-isoquinolina; procedimiento de preparación; composición farmacéutica; y su uso en el tratamiento de enfermedades pulmonares obstructvas crónicas (epoc) y asma. | |
| TR201905319T4 (tr) | Nevralji, ağrı, KOAH (Kronik, Obstruktif Akciğer Hastalığı) ve astım tedavisinde TRPM8-inhibitörleri olarak yararlı 2-aril-4-hidroksi-1,3-tiyazol türevleri. | |
| TR201720845A1 (tr) | Oral farmasöti̇k terki̇pler | |
| MX2016001539A (es) | Particulas inhalables que comprenden tiotropio e indacaterol. | |
| TR201720846A2 (tr) | Oral farmasöti̇k terki̇pler | |
| MX2021014116A (es) | Derivados de piridopirimidinas como inhibidores del purinoreceptor 3 de p2x (p2x3). | |
| MX2023005801A (es) | Derivados de ftalazina como inhibidores de purinoceptor 3 de p2x (p2x3). | |
| MX2023005805A (es) | Derivados de 4-aminas de (aza)quinolina como inhibidores del purinorreceptor 3 p2x (p2x3). | |
| TR201712424A2 (tr) | Kuru toz i̇nhalasyon bi̇leşi̇mleri̇ |